Carbotero 450 mg Inj

Carboplatin belongs to a class of chemotherapy medications known as platinum-based agents, which work by binding to the DNA within cancer cells, causing damage that prevents them from properly replicating and dividing. This disruption ultimately leads to the destruction of rapidly dividing cancer cells, helping slow tumor growth and progression. It is commonly used in the treatment of ovarian cancer, often as a first-line treatment combined with other chemotherapy agents, as well as non-small cell lung cancer and certain head and neck cancers. Carboplatin was developed as an alternative to Cisplatin, offering a generally more favorable side effect profile for many patients while maintaining effective anticancer activity, making it a valuable option in various treatment protocols. The medication is administered through intravenous infusion, typically in a hospital or specialized oncology setting, allowing healthcare providers to closely monitor the patient during and after administration. Treatment schedules and dosing are carefully individualized based on the specific type and stage of cancer, kidney function, and the patient's overall health and treatment history. Regular monitoring, including blood counts, is an important part of care throughout treatment to help guide safe and effective dosing. Many patients experience meaningful tumor response and improved disease management as part of a comprehensive cancer treatment plan involving Carboplatin. As with all chemotherapy medications, Carboplatin injection should be administered under the close supervision of an experienced oncology healthcare team.